Skip to main content

Table 3 Quality Evaluation of the Individual Studies

From: Gender differences in pulmonary arterial hypertension patients with BMPR2 mutation: a meta-analysis

Study ID

Q1

Q2

Q3

Q4

Q5

Austin 2009 [8]

Yes

No

Yes

Yes

Yes

Bruggen 2016 [12]

Yes

No

Yes

Yes

Yes

Chida 2012 [20]

Yes

No

Yes

No

No

Elliott 2006 [21]

Yes

No

Yes

Yes

Yes

Gamou 2017 [14]

Yes

No

Yes

Yes

Yes

Ghigna 2016 [10]

Yes

No

Yes

Yes

Yes

Girerd 2010 [9]

Yes

No

Yes

Yes

Yes

Isobe 2016 [18]

Yes

No

Yes

Yes

Yes

Kabata 2013 [13]

Yes

No

Yes

Yes

Yes

Liu 2012 [11]

Yes

No

Yes

Yes

Yes

Mutlu 2016 [23]

Yes

No

Yes

Yes

Yes

Navas 2016 [19]

Yes

No

Yes

Yes

Yes

Pfarr 2011 [17]

Yes

No

Yes

Yes

Yes

Pousada 2014 [22]

Yes

No

Yes

Yes

Yes

Rosenzweig 2008 [24]

Yes

No

Yes

Yes

Yes

Sztrymf 2008 [15]

Yes

No

Yes

Yes

Yes

Yang 2018 [16]

Yes

No

Yes

Yes

Yes

  1. Q question; Q1 (external validity): Did the patients represent a variety of disease severities?; Q2 (external validity): Did the included study exhibit bias?; Q3 (internal validity): Was the follow-up percentage of all enrolled patients greater than 80%?; Q4 (internal validity): Were the predictors to be evaluated blinded to the outcome events?; Q5 (internal validity): Were the outcome events blinded to the predictors?